[DOI] [PMC free article] [PubMed] [Google Scholar] 82.Wiegand A., Friske M., Edelmann S., Bender A., Fischer L., Zill P., Koller G., Bakalkin G., Sommer W.H., Hansson A.C., et al
However, in the only randomized, placebo-controlled pilot study to date examining fecal microbiota transplantation in 11 patients with ME/CFSwhere 5 patients received transplants from a universal donor and 6 underwent autologous fecal microbiota transplantation through colonoscopythere were no notable differences in health-related quality of life metrics between the treatment and placebo groups at both 1- and 6-months post-treatment [163]
Confusion with precursors
et al (2018) Mitochondrial Dysfunction and Oxidative Stress in Metabolic DisordersA Step Towards Mitochondria Based Therapeutic Strategies Luo, Y
Safety and Efficacy of Glutathione in Dermatology